Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2003
11/18/2003US6649390 Thermophilic alkaline phosphoesterase and its expression
11/18/2003US6649389 Peptide for use in the diagnosis and treatment of cancer, thyroid, diabetes, atherosclerosis, and cardiovascular disorders
11/18/2003US6649388 Polypeptides derived from JNK3
11/18/2003US6649387 Enzymatic oxidative deamination process
11/18/2003US6649385 Isolated nucleic acid molecules encoding human squalene synthase proteins, and related products and processes
11/18/2003US6649382 Methods of making polyhydroxyalkanoate using biosynthesis genes from alcaligenes latus
11/18/2003US6649379 Gene isolated from Corynebacterium glutamicum, Escherichia coli, and Bacillus subtilis, encoding a homoserine dehydrogenase; mutated in carboxy terminus to prevent end-product inhibition; biosynthesis
11/18/2003US6649377 Human aggrecanase and nucleic acid compositions encoding the same
11/18/2003US6649375 Adenoviral vectors for enhanced gene expression
11/18/2003US6649369 Process for delaying the deactivation of glutaryl amidase during enzyme catalysis
11/18/2003US6649364 Anti-apoptotic compositions and methods using same
11/18/2003US6649363 Motor proteins and methods for their use
11/18/2003US6649355 Lipoxygenase proteins and nucleic acids
11/18/2003US6649345 Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders
11/18/2003US6649340 Protein which contains a predetermined amino acid in the hypervariable region of the antigen-binding site; use in studying structure/ function and in developing new enzymes and antibodies
11/18/2003US6649179 A plasminogen activator inhibitor comprising zinc oxide which adsorbs a plasminogen activator and inhibits its activity, thus improving rough skin
11/18/2003US6649166 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
11/18/2003CA2276109C Peptidomimetic inhibitors of the human cytomegalovirus protease
11/18/2003CA1341447C Mutant t-pa with kringle replacement
11/18/2003CA1341446C Tissue plasminogen activator analogs having modified growth factor domains
11/15/2003CA2382767A1 Plant fad2 coding sequence balancing for fatty acid profiling in edible oils
11/13/2003WO2003093786A2 Short enzyme donor fragment
11/13/2003WO2003093482A2 Method for producing multiple unsaturated fatty acids in plants
11/13/2003WO2003093477A1 Novel carbonyl reductase, gene thereof and use of the same
11/13/2003WO2003093475A1 Compositions and methods for the modification of gene expression_using the superubiquitin promoter from pinus radiata
11/13/2003WO2003093467A1 Proteins having an (r)-hydroxynitrile lyase activity and extracted from prunus laurocerasus and sorbus aucuparia
11/13/2003WO2003093466A1 Human rhomboid-related protein
11/13/2003WO2003093465A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS
11/13/2003WO2003093464A1 Compositions isolated from forage grasses and methods for their use
11/13/2003WO2003093459A1 Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof
11/13/2003WO2003093453A2 Bacillus licheniformis mutant host cell
11/13/2003WO2003093448A2 Recombinant glycosyltransferase fusion proteins
11/13/2003WO2003093439A2 Enzymes
11/13/2003WO2003093436A2 Treatment for phenylketonuria
11/13/2003WO2003093435A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/13/2003WO2003093432A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003WO2003093430A2 Methods and compositions for use in preparing sirnas
11/13/2003WO2003093428A2 Gene targeting using replicating dna molecules
11/13/2003WO2003093427A2 Molecules for disease detection and treatment
11/13/2003WO2003093425A2 Methods of identifying genes for the manipulation of triterpene saponins
11/13/2003WO2003093311A1 Proteins with deglycating activities and methods of using same
11/13/2003WO2003093303A1 Targeting proteins to deliver therapeutic or diagnostic reagents
11/13/2003WO2003093232A2 Feline pancreatic lipase composition and method of preparing and using such composition
11/13/2003WO2003093200A2 Method for synthesis of aryl-carotenoids
11/13/2003WO2003092618A2 Materials and methods for prevention and treatment of rna viral diseases
11/13/2003WO2003092612A2 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092607A2 Crystal structure of aurora-2 protein and binding pockets thereof
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003092598A2 Treatment for pompe disease
11/13/2003WO2003092594A2 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
11/13/2003WO2003092584A2 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
11/13/2003WO2003092363A2 Transgenic high tryptophan plants
11/13/2003WO2003092360A2 Novel glyphosate-n-acetyltransferase (gat) genes
11/13/2003WO2003068955A3 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/13/2003WO2003057853A3 Oxidative stress-resistant cell lines and methods of use thereof
11/13/2003WO2003045310A3 Digital assay
11/13/2003WO2003040372A3 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
11/13/2003WO2003040291A3 Genes encoding for carbon metabolism and energy-producing proteins
11/13/2003WO2003035673A9 Supercritical fluids processing: preparation of protein microparticles and their stabilisation
11/13/2003WO2003032713A3 COFFEE PLANT WITH REDUCED α-D-GALACTOSIDASE ACTIVITY
11/13/2003WO2003029404A3 MAST CELL RasGRP4 COMPOSITIONS AND RELATED METHODS
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022871A3 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
11/13/2003WO2003018830A3 METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE
11/13/2003WO2003018813A3 Ashbya gossypii enzymes
11/13/2003WO2003010281A3 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
11/13/2003WO2003010183A3 Process for preparing variant polynucleotides
11/13/2003WO2003008600A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
11/13/2003WO2003008534A3 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
11/13/2003WO2002102991A3 Crystals and structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase mecps
11/13/2003WO2002102984A3 Hdac9 polypeptides and polynucleotides and uses thereof
11/13/2003WO2002097074A3 Human protein phosphatase 2c-like enzyme
11/13/2003WO2002095002A3 N4 virion single-stranded dna dependent rna polymerase
11/13/2003WO2002090549A3 Compositions and methods for the modulation of viral maturation
11/13/2003WO2002079226A3 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
11/13/2003WO2002069198A3 Hla ligand database utilizing predictive algorithms and methods of making and using same
11/13/2003WO2002066671A3 Improved method for detection of atp
11/13/2003WO2002064796A8 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
11/13/2003WO2002062980A8 Process for the extraction of beta-amylase
11/13/2003WO2002062825A3 Detection of polymorphisms in the human 5-lipoxygenase gene
11/13/2003WO2002057226A8 68730 and 69112 protein kinase molecules and uses therefor
11/13/2003WO2002051992A9 21163, a novel human prolyl oligopeptidase and uses therefor
11/13/2003WO2000068248A8 Self assembling proteins
11/13/2003US20030213018 Comprises polypeptide coding cis-zeatin O-glucosyltransferase for increasing cytokinin production in plants; plant bioengineering for increased crop production
11/13/2003US20030213010 Comprises nucleotide sequences coding anthranilate synthase for increasing tryptophan concentration in animal feeds and human foods
11/13/2003US20030213003 Preparing and recoverng genetically engineered fusion protein for treating diabetes
11/13/2003US20030212262 Human serine racemase
11/13/2003US20030212030 Blood disorders; synergistic mixture of vector and monoclonal antibody
11/13/2003US20030212023 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
11/13/2003US20030212021 Myeloid colony stimulating factor and uses thereof
11/13/2003US20030211989 Genetic engineered cell; antibodies
11/13/2003US20030211977 Muscle relaxants; anticoagulants; cardiovascular disorders
11/13/2003US20030211965 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
11/13/2003US20030211958 Alpha-amylase mutants
11/13/2003US20030211608 Antisense modulation of glycogen synthase kinase 3 beta expression
11/13/2003US20030211606 Antisense modulation of DYRK4 expression
11/13/2003US20030211593 Comprises polymerase with modified exonuclease activity for use as amplification tool in DNA replication reactions
11/13/2003US20030211588 Methods for identifying agents that interact with an active site
11/13/2003US20030211586 Passivation of nerve agents by surface modified enzymes stabilized by non-covalent immobilization on robust, stable particles
1 ... 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 ... 1416